(Q36739259)

16 August 2017

1 reference

title

Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? (English)

1 reference

Hormone Replacement Therapy

16 August 2017

1 reference

Giuseppe M C Rosano

1

1 reference

16 August 2017

Cristiana Vitale

series ordinal

2

1 reference

16 August 2017

Massimo Fini

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Annals of the New York Academy of Sciences

16 August 2017

1 reference

16 August 2017

1092

1 reference

16 August 2017

341-348

1 reference

Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

16 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Postmenopausal use of estrogen and occlusion of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Risk factors and noncontraceptive estrogen use in women with and without coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Postmenopausal hormone therapy and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Decreased mortality in users of estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

The protective effects of estrogen on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

The emergence of the metabolic syndrome with menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Metformin improves endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

The epidemiology of the association between hypertension and menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1365.031

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1365.031

1 reference

16 August 2017

1 reference